Bioatla Investor Relations Material
Latest events
Q4 2023
Bioatla
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Bioatla Inc
Access all reports
Bioatla Inc is a clinical-stage biopharmaceutical company specializing in the development of novel monoclonal antibody and cell-based therapeutics for the treatment of solid tumor cancers. Utilizing its proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO) platforms, Bioatla is focused on creating therapies with improved selectivity for the tumor microenvironment, potentially enhancing safety and therapeutic efficacy. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States